Screener
10x Genomics, Inc. TXG Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s total equity?
- 10x Genomics, Inc. (TXG) reported total equity of $825.55M in Q2 2026.
- How has 10x Genomics, Inc.'s total equity changed year-over-year?
- 10x Genomics, Inc.'s total equity increased by 6.8% year-over-year, from $773.28M to $825.55M.
- What is the long-term trend for 10x Genomics, Inc.'s total equity?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s total equity has grown at a 1.5% compound annual growth rate (CAGR), from $739.07M to $796.33M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about 10x Genomics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude